SURVYR

POM

Pomdoctor Limited
$1.80
+$0.41 (29.50%)Oct 28 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-99%-65%-31%+3%+37%Oct 2025Oct 2026Apr 202652w high $115.7452w low $0.43
POMSPY
Wall St. Highest PT $139.08 (+7626.7%) Wall St. Avg PT $114.00 (+6233.3%)
$1$48$95$143$190POC $4Hi $139Avg $114
Underwater Drawdown %Max DD -99.5%Current -98.4%
0.0%-99.5%
Relative Strength vs SPY-111.8% vs SPYUnderperforming
+131%0%-131%
1W
−$1.21 (40.20%)
1M
+$0.89 (97.80%)
3M
+$1.10 (156.78%)
6M
−$4.90 (73.12%)
YTD
−$3.51 (66.10%)
1Y
−$84.96 (97.93%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for POM
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$12.7M
52-week range$0.43 – $115.74
Revenue growth (latest quarter vs a year ago)+6.0%
Dividend yieldNo dividend

What they do

Pomdoctor Limited offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products.

Healthcare · Pharmaceutical Retailers
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for POM yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

POM earningsNo upcoming date on file
Source: Yahoo Finance · refreshed 2026-10-21 11:24:18 ET
No EPS history available.

News & catalysts

More news
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
PR Newswire · Oct 19
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
PR Newswire · Oct 12
Pomdoctor Receives Nasdaq Delisting Determination
MT Newswires · Oct 09
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
PR Newswire · Oct 09
POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
PR Newswire · Sep 30

Stats refreshed 2026-10-21 11:24:18 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026